Tag: SBI-100

Small Biotech Unlocking Value Of Cannabinoids

| March 8, 2022
Small Biotech Unlocking Value Of Cannabinoids

Note: The following is an advertorial for Skye Bioscience… Glaucoma is the world’s leading cause of irreversible blindness and the leading cause of blindness in people over 60. Glaucoma affects nearly 80 million patients worldwide and is projected to reach 110 million by the year 2026. The current course of treatment for glaucoma represents a […]

Continue Reading